tiprankstipranks
Santhera Pharmaceuticals Holding (CH:SANN)
:SANN

Compare Santhera Pharmaceuticals Holding (SANN) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Santhera Pharmaceuticals Holding
CHF16.70
CHF237.10M
-0.98
25.49%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.41
CHF137.27M
-2.50
9.39%
1 Buy
0 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF52.60
CHF659.17M
16.63
36.93%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.43
CHF867.56M
-8.17
253.46%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF14.88
CHF309.59M
-9.69
141.80%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF21.50
CHF124.00M
3.99
13.16%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:SANN
Santhera Pharmaceuticals Holding
16.64
3.82
29.80%
CH:MOLN
Molecular Partners AG
3.38
0.15
4.48%
CH:BSLN
Basilea Pharmaceutica
54.50
15.05
38.15%
CH:IDIA
Idorsia Ltd
3.52
2.49
240.81%
CH:NWRN
Newron Pharmaceuticals SpA
15.04
9.01
149.42%
CH:XLS
Xlife Sciences Ltd.
21.50
2.10
10.82%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts